Mitochondrial retrograde signalling in neurological disease. (22nd June 2020)

• Record Type: Journal Article
• Authors: Granat, Lucy; Hunt, Rachel J.; Bateman, Joseph M.
• Is Part Of: Philosophical transactions. Volume 375:Number 1801(2020)
• Publication Date: 2020-06-22
• Subjects: mitochondria -- retrograde signalling -- disease -- neuron -- Parkinson's -- Alzheimer's; Biology -- Periodicals; Science -- Periodicals; 570
• DOI: 10.1098/rstb.2019.0415
• Languages: English
• ISSNs: 0962-8436

Abstract

Abstract : Neuronal mitochondrial dysfunction causes primary mitochondrial diseases and likely contributes to neurodegenerative diseases including Parkinson's and Alzheimer's disease. Mitochondrial dysfunction has also been documented in neurodevelopmental disorders such as tuberous sclerosis complex and autism spectrum disorder. Only symptomatic treatments exist for neurodevelopmental disorders, while neurodegenerative diseases are largely untreatable. Altered mitochondrial function activates mitochondrial retrograde signalling pathways, which enable signalling to the nucleus to reprogramme nuclear gene expression. In this review, we discuss the role of mitochondrial retrograde signalling in neurological diseases. We summarize how mitochondrial dysfunction contributes to neurodegenerative disease and neurodevelopmental disorders. Mitochondrial signalling mechanisms that have relevance to neurological disease are discussed. We then describe studies documenting retrograde signalling pathways in neurons and glia, and in animal models of neuronal mitochondrial dysfunction and neurological disease. Finally, we suggest how specific retrograde signalling pathways can be targeted to develop novel treatments for neurological diseases. This article is part of the theme issue 'Retrograde signalling from endosymbiotic organelles'.